Evaluation of Irisin Level in Iraqi Patients with Type 2 Diabetes and Pre-Diabetes Status as a Predictive Factor

Hiba Mohammed Hatem; Kadhim  Khudhair Ghudhaib

doi:10.30526/38.1.3630

Authors

Hiba Mohammed Hatem Department of Chemistry, College of Science for Women, University of Baghdad, Baghdad, Iraq. https://orcid.org/0009-0004-8122-8142
Kadhim Khudhair Ghudhaib Department of Chemistry, College of Science for Women, University of Baghdad, Baghdad, Iraq. https://orcid.org/0000-0003-4966-4070

DOI:

https://doi.org/10.30526/38.1.3630

Keywords:

HOMA-IR, HOMA-IS, insulin, irisin, pre-diabetes, type 2 diabetes mellitus

Abstract

The prevalence of diabetes is increasing rapidly and is now recognized as a significant global health problem. Diabetes occurs when a person does not produce enough insulin due to an imbalance in insulin production. This can lead to the failure of organs and tissues such as the kidneys, heart, blood vessels, eyes, nerves, and kidneys. As a result, early diagnosis and classification of type 2 diabetes mellitus (T2DM) are critical to aiding physician assessments. Subsequently, the current study aims to determine irisin levels in patients with T2DM and pre-DM as early predictors for disease cases. The current study included 138 subjects divided into three groups based on fasting blood glucose (FBG) and glycosylated hemoglobin criteria, including T2DM, 46 patients, pre-diabetes, 46 participants, and healthy subject groups, 46 persons) when they enrolled in the National Diabetes Center/ Al-Mustansiriya University. Enzyme-linked immunosorbent assays were used to detect the levels of irisin and insulin, and spectrophotometric techniques were used to determine the levels of FBG and lipid profile. The results of irisin revealed significant differences among the studied groups. Also, the insulin results showed substantial differences between the diabetic and control groups. Moreover, the results of HOM-IR and HOMA-IS and lipid profiles showed significant differences between the studied groups. The results showed that irisin can serve as an early indicator of pre-diabetes. These results were reinforced by the results of the ROC analysis, which indicated that irisin is an excellent indicator for diagnosing the studied condition.

Author Biographies

Hiba Mohammed Hatem , Department of Chemistry, College of Science for Women, University of Baghdad, Baghdad, Iraq.

.
Kadhim Khudhair Ghudhaib , Department of Chemistry, College of Science for Women, University of Baghdad, Baghdad, Iraq.

.

References

1. Van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CD. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol. 2020; 8(4):325-336. https://doi.org/10.1016/S2213-8587(19)30405-X.

2. Khan RMM, Chua ZJY, Tan JC, Yang Y, Liao Z, Zhao Y. From pre-diabetes to diabetes: Diagnosis, treatments, and translational research. Medicina (Kaunas). 2019; 55(9):546. https://doi.org/10.3390/medicina55090546.

3. Khaleel FM, Murtadha JH, Abdulrazzaq H. Estimation of blood (TG, TC, and LDL) as markers of lipid profile and urea, uric acid, and creatinine as markers of kidney function in diabetic patients. Res J Pharm Biol Chem Sci. 2019; 10(1):79-84. https://www.researchgate.net/publication/345877333.

4. Han YM, Yang H, Huang QL, Sun ZJ, Li ML, Zhang JB, Deng KJ, Chen S, Lin H. Risk prediction of diabetes and pre-diabetes based on physical examination data. Math Biosci Eng. 2022;19(4):3597-3600. https://doi.org/10.3934/mbe.2022166.

5. Farhan LO. Determination of several biochemical parameters in sera of Iraqi patients with type 2 diabetes. Baghdad Sci J. 2015; 12(2):362-370. ‏https://doi.org/10.21123/bsj.12.2.362.370.

6. Hamid GS, Allawi AA, Ghudhaib KK. Correlation of pentosidine with kidney diseases in Iraqi patients with diabetic nephropathy. Iraqi J Sci. 2021; 62:3436-3442.https://doi.org/10.24996/ijs.2021.62.10.2

7. Salman ZA, Ghudhaib KK. Association of osteopontin and alkaline phosphatase in male patients with diabetes mellitus type 2 and periodontitis. Iran J War Public Health. 2022; 14(1):105-109.

https://doi.org/10.29252/ijwph.14.1.105.

8. Salman ZA, Ghudhaib KK, Fadhil R. Evaluating osteocalcin and osteonectin in serum of male patients with type 2 diabetes mellitus and periodontitis. Eurasian Chem Commun. 2022; 4(4):295-302.

https://doi.org/10.22034/ecc.2022.325049.1307.

9. Shabir K, Brown JE, Afzal I, Gharanei S, Weickert MO, Barber TM, Kyrou I, Randeva HS. Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence. Cytokine Growth Factor Rev. 2021; 60:120-132. https://doi.org/10.1016/j.cytogfr.2021.05.002.

10. Miao Z, Alvarez M, Ko A, Bhagat Y, Rahmani E, Jew B, Heinonen S, Munoz-Hernandez LL, Herrera-Hernandez M, Aguilar-Salinas C, Tusie-Luna T. The causal effect of obesity on prediabetes and insulin resistance reveals the important role of adipose tissue in insulin resistance. PLOS Genet. 2020; 16(9):e1009018. https://doi.org/10.1371/journal.pgen.1009018.

11. Echouffo-Tcheugui JB, Selvin E. Prediabetes and what it means: the epidemiological evidence. Annu Rev Public Health. 2021; 42(1):59-77. https://doi.org/10.1146/annurev-publhealth-090419-102644.

12. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018; 14(2):88-98. https://doi.org/10.1038/nrendo.2017.151.

13. Liu R, Zhang Q, Peng N, Xu S, Zhang M, Hu Y, Chen Z, Tang K, He X, Li Y, Shi L. Inverse correlation between serum irisin and cardiovascular risk factors among Chinese overweight/obese population. BMC Cardiovasc Disord. 2021; 21:1-8. https://doi.org/10.1186/s12872-021-02380-0.

14. Zaki M, Abdallah HR, El-Bassyouni HT, Tawfeek HM, Hanna H, Ashour MN, Youness ER. Circulating irisin in relation to obesity and anorexia nervosa in patients with type 2 diabetes. Egypt J Chem. 2022; 65(12):175-180. https://doi.org/10.21608/EJCHEM.2022.112977.5143.

15. Al-Attaby AK, Al-Lami MQ. Effect of age and gender on some biochemical, hormones and adipocytokines parameters in Iraqi type 2 diabetes mellitus patients. Int Res J Pharm. 2018; 9(12):51-58. https://doi.org/10.7897/2230-8407.0912286.

16. Lai Y, Qi J, Tao X, Huang K, Yan S, Chen M, Hao J, Tao F. Associations of grandparental diabetes mellitus with grandchild BMI status. BMC Public Health. 2019; 19:1-8. https://doi.org/10.1186/s12889-019-6485-y.

17. Nuttall FQ. Body mass index: obesity, BMI, and health: a critical review. Nutr Today. 2015; 50(3): 117-128. https://doi.org/10.1097/NT.0000000000000092.

18. Evers J, Grotenhuis AJ, Aben KK, Kiemeney LA, Vrieling A. No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression. PLOS One. 2020; 15(3):e0229384. https://doi.org/10.1371/journal.pone.0229384.

19. Awasthi A, Rao CR, Hegde DS. Association between type 2 diabetes mellitus and anthropometric measurements: a case-control study in South India. J Prev Med Hyg. 2017; 58(1):E56.

https://doi.org/10.15167/2421-4248/jpmh2017.58.1.648.

20. Sun Y, Liu B, Snetselaar LG, Wallace RB, Caan BJ, Rohan TE, Bao W. Association of normal-weight central obesity with all-cause and cause-specific mortality among postmenopausal women. JAMA Netw Open. 2019; 2(7):e197337-e197337. https://doi.org/10.1001/jamanetworkopen.2019.7337.

21. Elimam H, Abdulla AM, Taha IM. Inflammatory markers and control of type 2 diabetes mellitus. Diabetes Metab Syndr Clin Res Rev. 2019; 13(1):800-804. https://doi.org/10.1016/j.dsx.2018.11.061.

22. Misra A, Bloomgarden ZT. Discordance between HbA1c and glycemia. J Diabetes. 2018; 10:908–910. https://doi.org/10.1111/1753-0407.12843.

23. Mohsen IH, Zaidan HK, Al-Saadi AH. Interaction of insulin hormone with microalbuminuria and blood pressure in type 2 diabetic patients. J Univ Babylon. 2016; 24(5):1493-1500.

24. Wali JA, Thomas HE, Sutherland APR. Linking obesity with type 2 diabetes: The role of T-bet. Diabetes Metab Syndr Obes. 2014;7:331-340. https://doi.org/10.2147/DMSO.S51432.

25. Al-Attaby AKT, Al-Lami MQD. Role of calcium-regulating hormones, adipocytokines and renal function tests in the progress of type 2 diabetes mellitus in a sample of Iraqi patients. Iraqi J Agric Sci. 2019; 50(1):343-351. https://doi.org/10.36103/ijas.v50i1.300.

26. Yassin MM, Altibi HI, El Shanti AE. Clinical and biochemical features of type 2 diabetic patients in Gaza Governorate, Gaza Strip. West Afr J Med. 2011; 30(1):51-56. https://doi.org/10.4314/wajm.v30i1.69918.

27. Ali EE, Dafalla AM, Mohammed YA, Nour BY. Correlation between serum CD36 level and lipid profile in patients with type 2 diabetes mellitus, Khartoum State, Sudan. J Diabetes Mellitus. 2023;13(1):68-75. https://doi.org/10.4236/jdm.2023.131007.

28. Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, Park KG. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract. 2013; 100(1):96-101. https://doi.org/10.1016/j.diabres.2013.01.007.

29. Shoukry A, Shalaby SM, El‐Arabi Bdeer S, Mahmoud AA, Mousa MM, Khalifa A. Circulating serum irisin levels in obesity and type 2 diabetes mellitus. IUBMB Life. 2016; 68(7):544-556. https://doi.org/ 10.1002/iub.1511.

30. Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Fernández-Real JM. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance.J Clin Endocrinol Metab. 2013; 98(4):E769-E778.https://doi.org/10.1210/jc.2012-2749.

31. Huh JH, Ahn SV, Choi JH, Koh SB, Chung CH. High serum irisin level as an independent predictor of diabetes mellitus: a longitudinal population-based study. Medicine (Baltimore). 2016; 95(23):e3742. https://doi.org/10.1097/MD.0000000000003742.

32. Al-Daghri NM, Alokail MS, Rahman S, Amer OE, Al-Attas O, Alfawaz H, Tripathi G, Sabico S, Chrousos GP, McTernan PG, Piya MK. Habitual physical activity is associated with circulating irisin in healthy controls but not in subjects with diabetes mellitus type 2. Eur J Clin Invest. 2015; 45(8):775-781. https://doi.org/10.1111/eci.12468.

33. Park K, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE, Mantzoros CS. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013; 98(12): 4899-4907. https://doi.org/10.1210/jc.2013-2373.